🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine how the body absorbs decitabine w...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT00941109
Treatments Being Tested
This is an open-label, single-center, two part study in healthy female subj...
Status
Completed
Location
Quotient Sciences
Start Date
2021-01-07
Trial ID
NCT04680273
Treatments Being Tested
The primary objective of this study is to assess the absolute bioavailabili...
Status
Completed
Location
Teva Investigational Site 10567
Start Date
2013-06
Trial ID
NCT01990443
Treatments Being Tested
This is a Phase I single center, open-label, non-randomized study in health...
Status
Completed
Location
Quotient Sciences
Start Date
2020-11-25
Trial ID
NCT04649216
Treatments Being Tested
The study is divided into two parts - Part A and Part B. Cagrilintide in co...
Status
Completed
Location
Pharmaceutical Research Associates CZ, s.r.o.
Start Date
2023-04-05
Trial ID
NCT05564104
Treatments Being Tested
In this study, a 10 mg dose of CP-690,550 will be given to study subjects o...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01143805
Treatments Being Tested
This open-label, randomized, 2-way crossover study will assess the absolute...
Status
Completed
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01802853
This study is intended to estimate the absolute bioavailability of Glasdegi...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2017-09-07
Trial ID
NCT03270878
Treatments Being Tested
The primary objective of this trial is to investigate the absolute oral bio...
Status
Completed
Location
ICON
Start Date
2019-01-15
Trial ID
NCT03783000
Treatments Being Tested
This is a study in healthy male volunteers to assess how a new test medicin...
Status
Completed
Location
Quotient Sciences Limited
Start Date
2022-04-19
Trial ID
NCT05335447
Treatments Being Tested